Literature DB >> 6386040

Doppler blood flow waveforms in the descending thoracic aorta of the human fetus.

D Griffin, K Bilardo, L Masini, J Diaz-Recasens, J M Pearce, K Willson, S Campbell.   

Abstract

A linear-array pulsed Doppler duplex has been used to study third-trimester Doppler flow velocity waveforms (FVW) in the descending thoracic aorta of 98 normal and 20 severely growth-retarded fetuses. Waveforms have been normalized (frequency index profile; FIP) to remove the effect of the angle of insonation and so allow comparison at different gestational ages and with complicated pregnancies. There is an increase in end-diastolic velocities with advancing gestational age indicating a reduction in placental resistance. The growth-retarded fetuses showed a significant reduction in end-diastolic velocities and an increase in the pulsatility index (normal PI: mean 1.83, SD 0.22; growth-retarded PI: mean 2.78, SD 0.60). This reduction of diastolic blood flow may indicate reduced placental vascularity and predict impending fetal hypoxia.

Entities:  

Mesh:

Year:  1984        PMID: 6386040     DOI: 10.1111/j.1471-0528.1984.tb03678.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  Intrauterine growth retardation.

Authors:  M L Chiswick
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28

2.  Doppler studies in the growth retarded fetus and prediction of neonatal necrotising enterocolitis, haemorrhage, and neonatal morbidity.

Authors:  G A Hackett; S Campbell; H Gamsu; T Cohen-Overbeek; J M Pearce
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

3.  Fetal circulation 60 to 80 minutes after vaginal prostaglandin E2 in pregnant women at term.

Authors:  A Lindblad; G Ekman; K Marsál; U Ulmsten
Journal:  Arch Gynecol       Date:  1985

Review 4.  The placental pursuit for an adequate oxidant balance between the mother and the fetus.

Authors:  Emilio A Herrera; Bernardo Krause; German Ebensperger; Roberto V Reyes; Paola Casanello; Mauro Parra-Cordero; Anibal J Llanos
Journal:  Front Pharmacol       Date:  2014-06-24       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.